NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT01607905 2023-01-26Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor CancerKaryopharm Therapeutics IncPhase 1 Completed192 enrolled 29 charts